1. Home
  2. ESPR vs LFMD Comparison

ESPR vs LFMD Comparison

Compare ESPR & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.66

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.51

Market Cap

190.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
LFMD
Founded
2008
1994
Country
United States
United States
Employees
N/A
384
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
190.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ESPR
LFMD
Price
$2.66
$3.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$7.60
$9.14
AVG Volume (30 Days)
5.2M
1.3M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
$2.92
$16.11
Revenue Next Year
N/A
$20.07
P/E Ratio
N/A
N/A
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$2.60
52 Week High
$4.18
$15.34

Technical Indicators

Market Signals
Indicator
ESPR
LFMD
Relative Strength Index (RSI) 41.86 46.19
Support Level $2.37 $3.43
Resistance Level $3.02 $4.19
Average True Range (ATR) 0.18 0.26
MACD 0.03 -0.08
Stochastic Oscillator 37.62 7.20

Price Performance

Historical Comparison
ESPR
LFMD

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

Share on Social Networks: